BRILINTA-60MG-14 TABLETS (Ticagrelor 60 mg) Antiplatelet Tablets
BRILINTA-60MG-14 TABLETS contain Ticagrelor 60 mg, a prescription antiplatelet medicine that helps reduce the risk of heart attack, stroke, and cardiovascular death in eligible high-risk patients.
BRILINTA-60MG-14 TABLETS
BRILINTA-60MG-14 TABLETS (Ticagrelor 60 mg): Comprehensive Guide and Benefits
Introduction to BRILINTA-60MG-14 TABLETS (Ticagrelor 60 mg)
BRILINTA-60MG-14 TABLETS (Ticagrelor 60 mg): A P2Y12 Antiplatelet Medication
BRILINTA-60MG-14 TABLETS are a prescription-only antiplatelet medicine containing Ticagrelor 60 mg. Ticagrelor belongs to the P2Y12 platelet receptor inhibitor class and is used to reduce the risk of cardiovascular death, heart attack (myocardial infarction), and stroke in appropriate patients with a history of myocardial infarction or coronary artery disease who are at high risk of thrombotic events. It is commonly prescribed with low-dose aspirin unless otherwise directed by a healthcare provider.
Ticagrelor prevents platelets from sticking together, thereby reducing the formation of blood clots that can obstruct blood flow to the heart or brain. Because it increases the risk of bleeding, treatment should be supervised by a qualified healthcare professional. Patients should not stop taking BRILINTA without medical advice, as this may increase the risk of serious cardiovascular events.
Key Benefits of BRILINTA-60MG-14 TABLETS (Ticagrelor 60 mg)
Helps reduce the risk of heart attack and ischemic stroke.
Lowers the risk of cardiovascular death in eligible patients.
Prevents platelet aggregation and harmful blood clot formation.
Supports long-term secondary prevention following myocardial infarction.
Provides effective and reversible platelet inhibition.
How BRILINTA-60MG-14 TABLETS (Ticagrelor 60 mg) Works
Ticagrelor is a reversible P2Y12 adenosine diphosphate (ADP) receptor antagonist that inhibits platelet activation and aggregation by blocking ADP-mediated signaling. Unlike certain other antiplatelet agents, it does not require metabolic activation, allowing for rapid onset of action. This mechanism reduces the formation of arterial thrombi that can lead to heart attack, stroke, or other cardiovascular complications.
Usage Instructions for BRILINTA-60MG-14 TABLETS
Take the medicine exactly as prescribed by your healthcare provider.
Swallow the tablet whole with water, with or without food.
Take one tablet twice daily unless otherwise directed.
Use low-dose aspirin only if recommended by your physician.
Attend regular follow-up appointments to monitor treatment effectiveness and bleeding risk.
Medicinal Advantages of BRILINTA-60MG-14 TABLETS
Proven to reduce major cardiovascular events in eligible patients.
Provides consistent platelet inhibition for long-term protection.
Helps reduce recurrent heart attacks after previous myocardial infarction.
Supports secondary prevention of thrombotic cardiovascular events.
Backed by extensive clinical research in cardiovascular medicine.
NOTE: BRILINTA-60MG-14 TABLETS are prescription-only medicines. They are contraindicated in patients with active pathological bleeding or a history of intracranial hemorrhage. Do not discontinue treatment without consulting your physician.
Off-Label Uses of BRILINTA-60MG-14 TABLETS
Healthcare professionals may occasionally prescribe ticagrelor for selected cardiovascular situations based on current clinical evidence and individual patient assessment.
Selected high-risk coronary artery disease management.
Specialist-directed prevention of thrombotic complications.
Individualized long-term antiplatelet therapy in complex cardiovascular patients.
Disclaimer: Off-label uses should only occur under physician supervision and may not be approved in all countries.
Expert Advice for Optimal Use
Take every dose at the same time each day.
Never stop treatment without consulting your cardiologist.
Inform your healthcare provider before any surgery or dental procedure.
Report unusual bruising or prolonged bleeding immediately.
Avoid taking NSAIDs unless approved by your physician.
Carry a medication list or medical alert card while receiving treatment.
Precautions
Cardiovascular Health
Continue therapy exactly as prescribed. Premature discontinuation may significantly increase the risk of heart attack, stroke, or cardiovascular death.
Liver & Kidney Function
Use cautiously in patients with severe hepatic impairment. Routine monitoring may be appropriate based on clinical status.
Pregnancy & Breastfeeding
Use during pregnancy or breastfeeding only when the expected benefits outweigh potential risks and under medical supervision.
Drug Interactions
Ticagrelor may interact with strong CYP3A inhibitors or inducers, anticoagulants, NSAIDs, digoxin, and other medicines that increase bleeding risk. Always inform your healthcare provider about all medicines, herbal products, and supplements you are taking.
Existing Medical Conditions
Inform your healthcare provider if you have active bleeding, stomach ulcers, liver disease, asthma, bleeding disorders, or require planned surgery before starting treatment.
Storage Instructions
Store below 30°C.
Keep the tablets in the original blister pack.
Protect from moisture and direct sunlight.
Keep out of the reach of children.
Do not use after the expiry date.
Frequently Asked Questions (FAQs)
Q: What is BRILINTA-60MG-14 TABLETS used for?
A: It is used to reduce the risk of cardiovascular death, heart attack, and stroke in eligible high-risk patients with coronary artery disease or a previous heart attack.
Q: What is the active ingredient in BRILINTA-60MG-14 TABLETS?
A: Each tablet contains Ticagrelor 60 mg, a P2Y12 platelet inhibitor.
Q: Should BRILINTA be taken with aspirin?
A: In many patients, BRILINTA is prescribed together with low-dose aspirin unless your healthcare provider recommends otherwise.
Q: What are the common side effects?
A: Common side effects include bleeding, bruising, nosebleeds, shortness of breath (dyspnea), and gastrointestinal discomfort. Seek immediate medical attention for severe bleeding.
Q: Can I stop taking BRILINTA-60MG-14 TABLETS on my own?
A: No. Stopping treatment without medical advice may increase the risk of heart attack, stroke, or other serious cardiovascular events.
Q: Can I take painkillers while using BRILINTA?
A: Some pain relievers, especially NSAIDs, may increase bleeding risk. Consult your healthcare provider before taking additional medications.
Q: Is BRILINTA-60MG-14 TABLETS available without a prescription?
A: No. It is a prescription-only medicine and should only be used under the supervision of a qualified healthcare professional.
Product Tags
BRILINTA-60MG-14 TABLETS, Ticagrelor 60 mg, Ticagrelor Tablet, P2Y12 Inhibitor, Antiplatelet Medicine, Blood Thinner Tablet, Heart Attack Prevention, Stroke Prevention, Cardiovascular Medicine, Coronary Artery Disease Treatment, Secondary Prevention After MI, Prescription Antiplatelet, Platelet Aggregation Inhibitor, Blood Clot Prevention, Long-Term Antiplatelet Therapy, Heart Disease Medication, Ticagrelor Prescription, BRILINTA Tablet, Cardiovascular Risk Reduction, Dual Antiplatelet Therapy
